Skip to content

The effect of immediate postoperative high-flow nasal cannula on oxygenation in obese and overweigh patients undergoing thoracoscopic one-lung ventilation

The effect of immediate postoperative high-flow nasal cannula on oxygenation in obese and overweigh patients undergoing thoracoscopic one-lung ventilation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110135
Enrollment
Unknown
Registered
2025-10-09
Start date
2025-10-09
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung injury

Interventions

HFNC group:Immediately after extubation, patients receive high-flow nasal cannula (HFNC) oxygen therapy using the AIRVO 2 device with a flow rate of 50–60 L/min, initial FiO% of 50% adjusted to mainta
Control Group:Immediately after extubation, patients receive conventional face mask oxygen therapy at a flow rate of 6–8 L/min for 2 hours.

Sponsors

The First Affiliated Hospital of Bengbu Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 72 Years

Inclusion criteria

Inclusion criteria: The study participants were obese (BMI = 25 kg/m²) patients scheduled to undergo thoracoscopic surgery with one-lung ventilation under general anesthesia, meeting the following criteria: 1. Aged 18–72 years 2. BMI = 25 kg/m² 3. ASA physical status classification of I–III 4. Scheduled for elective thoracoscopic surgery with one-lung ventilation, with an anticipated operative duration of 1–3 hours

Exclusion criteria

Exclusion criteria: Patients presenting with any of the following conditions were excluded from the study: 1. Refusal to sign informed consent; 2. History of acute respiratory infection within 2 weeks prior to surgery; 3. Communication barriers due to psychiatric disorders, language impairment, or visual/hearing impairments; 4. Scheduled operative duration 3 hours; 5. Comorbid severe COPD, asthma, or other restrictive ventilatory disorders; 6. Preoperative requirement for continuous oxygen therapy or dependence on non-invasive/invasive ventilator support; 7. Severe cardiac dysfunction (NYHA class IV), abnormal liver function (Child-Pugh grade C), severe renal dysfunction (requiring preoperative dialysis), or ASA physical status =IV; 8. Intraoperative conversion to open thoracotomy; 9. Other conditions deemed by the investigators or attending physician to render the patient unsuitable for study participation.

Design outcomes

Primary

MeasureTime frame
oxygenation index (PaO%/FiO%);

Secondary

MeasureTime frame
sRAGE;Frequency and duration of hypoxemic events (SpO? <92%) within 72 h postoperatively.;Incidence of respiratory complications (pneumonia, reintubation, ARDS, respiratory failure, etc.).;ICU and total hospital length of stay;

Countries

China

Contacts

Public ContactBiao Xi

The First Affiliated Hospital of Bengbu Medical University

xibiao01@163.com+86 189 5529 8188

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026